Irvine’s Allergan Drops Bid To Market Lap-Band to Teens
Irvine-based Allergan has withdrawn its application for FDA approval to market its Lap-Band weight-loss device to adolescents as young as 14, citing a routine evaluation of business priorities. Health experts and patient safety advocates have said that there is not enough data on the long-term safety and effectiveness of the device, especially among young patients.
- "Allergan Drops Bid for FDA Approval To Promote Lap-Band for Teens" (Terhune, Los Angeles Times, 10/3).